17:03 EDT I-Mab (IMAB) files $250M mixed securities shelf
Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on IMAB:
- I-Mab’s Givastomig Study Accepted for ESMO GI 2025 Presentation
- I-Mab’s Transformative Year: Financial and Strategic Highlights
- I-Mab Positions for Growth with U.S. Focus and Innovative Cancer Treatments
- Promising Pipeline and Strong Financial Position Drive Buy Rating for I-Mab
- I-Mab price target lowered to $7 from $8 at H.C. Wainwright